结节缩作为GAD,PD和OCD中认知和功能性脑损伤的共享结构基础:与共享基因表达和治疗影响的联系
Haohao Yan1, Yiding Han1, Xiaoxiao Shan1
1Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Journal of affective disorders
|October 16, 2025
概括
结节缩是普遍焦虑症,恐慌症和强迫症中共同存在的大脑缺陷,与遗传因素和认知问题有关. 这一发现为诊断和治疗反应提供了潜在的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 遗传学 遗传学 是一个
背景情况:
- 之前的研究记录了GAD,PD和OCD分别存在的结构性大脑缺陷.
- 整合在这些疾病的统一框架内仍然未被探索.
- 这项研究旨在确定这些疾病中共享的神经生理基础,遗传联系,功能障碍和潜在的生物标志物.
研究的目的:
- 调查在GAD,PD和OCD中共享的结构性大脑变化 (SCs).
- 探索与这些SCs的遗传关联.
- 检查与SCs相关的功能性脑损伤,并评估形态测量作为诊断和治疗生物标志物.
主要方法:
- 100名GAD,58名PD,45名强迫症患者和85名对照患者接受了MRI扫描和临床评估.
- 分析包括形态学,功能连接性 (FC),格兰杰因果分析 (GCA),基因表达相关性和机器学习.
- 在帕洛克塞丁治疗前和后进行了评估.
主要成果:
- 结节缩 (CA) 被确定为在GAD,PD和OCD中常见的SC.
- 发现了与灰质体积 (GMV) 改变的共同遗传关联,与神经发育和细胞生长调节 (ND-CGR) 有关.
- CA破坏了情绪和认知控制网络,机器学习显示了使用环状形态学进行分类和治疗预测的前景.
结论:
- 结节缩是GAD,PD和OCD中共享的神经基质.
- 这种缩与ND-CGR的遗传干扰,认知缺陷和功能性大脑损伤有关.
- 针状形态学显示出作为诊断和预测治疗反应的生物标志物的潜力.
相关概念视频
Obsessive-Compulsive Disorder
511
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
511
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Biological Causes of Schizophrenia
486
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
486
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K


